0001144204-13-029581.txt : 20130515
0001144204-13-029581.hdr.sgml : 20130515
20130515163807
ACCESSION NUMBER: 0001144204-13-029581
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130331
FILED AS OF DATE: 20130515
DATE AS OF CHANGE: 20130515
EFFECTIVENESS DATE: 20130515
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Knoll Capital Management, LP
CENTRAL INDEX KEY: 0001325083
IRS NUMBER: 133476926
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-11424
FILM NUMBER: 13847783
BUSINESS ADDRESS:
STREET 1: 666 FIFTH AVENUE
STREET 2: 37TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10103
BUSINESS PHONE: 212-808-7474
MAIL ADDRESS:
STREET 1: 666 FIFTH AVENUE
STREET 2: 37TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10103
13F-HR
1
v345102_13f.txt
13F-HR
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 13 F
FORM 13F COVER PAGE
Report for the Calendar Year or Quarter Ended: March 31, 2013
Check here if Amendment [ ]; Amendment Number:
This Amendment (check one only): [ ] is a restatement.
[ ] adds new holdings entries.
Institutional Investment Manager Filing this Report:
Name: Knoll Capital Management, L.P.
Address: 5 East 44th Street
New York, NY 10011
Form 13F File Number: 28-11424
The institutional investment manager filing this report and the person by whom
it is signed hereby represent that the person signing the report is authorized
to submit it, that all information contained herein is true, correct and
complete, and that it is understood that all required items, statements,
schedules, lists, and tables, are considered integral parts of this form.
Person Signing this Report on Behalf of Reporting Manager:
Name: Fred Knoll
Name: President
Phone: 212-479-6440
Signature, Place and Date of Signing:
/s/ Fred Knoll New York, NY May 14, 2013
-------------------- ------------- -----------------
[Signature] [City, State] [Date]
Report Type (Check only one):
[X] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager
are reported in this report.)
[ ] 13F NOTICE. (Check here if no holdings reported are in this report, and
all holdings are reported by other reporting manager(s).)
[ ] 13F COMBINATION REPORT. (Check here if a portion of the holdings for
this reporting manager are reported in this report and a portion are
reported by other reporting manager(s).)
List of Other Included Managers:
Provide a numbered list of the name(s) and Form 13F file number(s) of all
institutional investment managers with respect to which this report is filed,
other than the manager filing this report.
NONE
FORM 13F SUMMARY PAGE
Report Summary:
Number of Other Included Managers: 0
Form 13F Information Table Entry Total: 10
Form 13F Information Table Value Total: $137,184
(thousands)
List of Other Included Managers:
Provide a numbered list of the name(s) and Form 13F file number(s) of all
institutional investment managers with respect to which this report is filed,
other than the manager filing this report.
NONE
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F INFORMATION TABLE
------------------------------------------------------------------------------------------------------------------------------------
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
------------------------------------------------------------------------------------------------------------------------------------
VOTING AUTHORITY
-----------------------------
ISSUER NAME CLASS TITLE CUSIP VALUE SHRS OR PRN SH/ PUT/ INVESTMENT OTHER SOLE SHARED NONE
(x$1000) AMT PRN CALL DISCRETION MANAGERS
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
CNO Financial Group, Inc. Com 12621E103 3,395 296,470 SH SOLE NONE 296,470 - -
------------------------------------------------------------------------------------------------------------------------------------
Medivation, Inc. Com 58501N101 118,027 2,524,101 SH SOLE NONE 2,574,101 - -
------------------------------------------------------------------------------------------------------------------------------------
Sequenom Inc. Com New 817337405 3,852 928,100 SH SOLE NONE 928,100 - -
------------------------------------------------------------------------------------------------------------------------------------
Dendreon Corp. Com 24823Q107 1,224 258,200 SH SOLE NONE 258,200 - -
------------------------------------------------------------------------------------------------------------------------------------
Achillion Pharmaceuticals
Inc. Com 00448Q201 875 100,000 SH SOLE NONE 100,000 - -
------------------------------------------------------------------------------------------------------------------------------------
Echo Therapeutics Inc. Com 27876L107 351 444,445 SH SOLE NONE 444,445 - -
------------------------------------------------------------------------------------------------------------------------------------
Ampio Pharmaceuticals Inc. Com 03209T109 4,592 1,004,776 SH SOLE NONE 1,004,776 - -
------------------------------------------------------------------------------------------------------------------------------------
Vivus Inc. Call 928551900 1,470 5,000 SH Call SOLE NONE 5,000
------------------------------------------------------------------------------------------------------------------------------------
Genworth Financial Inc. Com Cl A 37247D106 3,200 320,000 SH SOLE NONE 320,000 - -
------------------------------------------------------------------------------------------------------------------------------------
Celgene Corp. Com 151020112 198 27,825 SH SOLE NONE 27,825 - -
------------------------------------------------------------------------------------------------------------------------------------